Giancarlo Comi

3.0k total citations
37 papers, 1.5k citations indexed

About

Giancarlo Comi is a scholar working on Pathology and Forensic Medicine, Neurology and Oncology. According to data from OpenAlex, Giancarlo Comi has authored 37 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pathology and Forensic Medicine, 11 papers in Neurology and 9 papers in Oncology. Recurrent topics in Giancarlo Comi's work include Multiple Sclerosis Research Studies (34 papers), Peripheral Neuropathies and Disorders (10 papers) and Polyomavirus and related diseases (6 papers). Giancarlo Comi is often cited by papers focused on Multiple Sclerosis Research Studies (34 papers), Peripheral Neuropathies and Disorders (10 papers) and Polyomavirus and related diseases (6 papers). Giancarlo Comi collaborates with scholars based in Italy, United States and Germany. Giancarlo Comi's co-authors include Angelo Ghezzi, Massimo Filippi, Lucia Moiola, Carlo Pozzilli, María Trojano, Maria Pia Amato, Mauro Zaffaroni, Francesco Patti, Vittorio Martinelli and Patricia K. Coyle and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Annals of Neurology.

In The Last Decade

Giancarlo Comi

36 papers receiving 1.4k citations

Peers

Giancarlo Comi
Katharine Harding United Kingdom
Norman Putzki Switzerland
Carolyn Bevan United States
Emma Tallantyre United Kingdom
Bettina Stubinski Switzerland
Giancarlo Comi
Citations per year, relative to Giancarlo Comi Giancarlo Comi (= 1×) peers B. Weinstock‐Guttman

Countries citing papers authored by Giancarlo Comi

Since Specialization
Citations

This map shows the geographic impact of Giancarlo Comi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giancarlo Comi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giancarlo Comi more than expected).

Fields of papers citing papers by Giancarlo Comi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giancarlo Comi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giancarlo Comi. The network helps show where Giancarlo Comi may publish in the future.

Co-authorship network of co-authors of Giancarlo Comi

This figure shows the co-authorship network connecting the top 25 collaborators of Giancarlo Comi. A scholar is included among the top collaborators of Giancarlo Comi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giancarlo Comi. Giancarlo Comi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Costa, Gloria Dalla & Giancarlo Comi. (2025). Updates on immunosuppressant safety and malignancy risk in patients with multiple sclerosis. Expert Opinion on Drug Safety. 25(1). 71–87.
2.
Dini, Michelangelo, et al.. (2024). A Review on the Feasibility and Efficacy of Home-Based Cognitive Remediation in People with Multiple Sclerosis. Journal of Clinical Medicine. 13(7). 1916–1916. 1 indexed citations
4.
Aktaş, Orhan, Focke Ziemssen, Tjalf Ziemssen, et al.. (2020). RENEWED: Long-Term Electrophysiological and Clinical Outcomes in Participants Previously Enrolled in the Opicinumab Phase 2 Study RENEW (1599). Neurology. 94(15_supplement). 4 indexed citations
5.
Zaratin, Paola, Giancarlo Comi, & David Leppert. (2017). ‘Progressive MS – macro views’: The need for novel clinical trial paradigms to enable drug development for progressive MS. Multiple Sclerosis Journal. 23(12). 1649–1655. 4 indexed citations
6.
Annovazzi, Pietro, Marco Capobianco, Lucia Moiola, et al.. (2016). Rituximab in the treatment of Neuromyelitis optica: a multicentre Italian observational study. Journal of Neurology. 263(9). 1727–1735. 40 indexed citations
7.
Laroni, Alice, Davide Brogi, Vincenzo Brescia Morra, et al.. (2014). Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial. BMC Neurology. 14(1). 65–65. 44 indexed citations
8.
Leist, Thomas, Giancarlo Comi, Bruce Cree, et al.. (2014). Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trial. The Lancet Neurology. 13(3). 257–267. 184 indexed citations
9.
Rocca, Maria A., Paola Valsasina, Martina Absinta, et al.. (2014). Intranetwork and internetwork functional connectivity abnormalities in pediatric multiple sclerosis. Human Brain Mapping. 35(8). 4180–4192. 39 indexed citations
10.
Stefano, Nicola De, Giancarlo Comi, Ludwig Kappos, et al.. (2013). Efficacy of subcutaneous interferon  -1a on MRI outcomes in a randomised controlled trial of patients with clinically isolated syndromes. Journal of Neurology Neurosurgery & Psychiatry. 85(6). 647–653. 21 indexed citations
11.
Comi, Giancarlo, Mario Alberto Battaglia, Antonio Bertolotto, et al.. (2013). Italian multicentre observational study of the prevalence of CCSVI in multiple sclerosis (CoSMo study): rationale, design, and methodology. Neurological Sciences. 34(8). 1297–1307. 14 indexed citations
12.
Cosentino, Marco, Mauro Zaffaroni, María Trojano, et al.. (2012). Dopaminergic Modulation of CD4+CD25<sup>high</sup> Regulatory T Lymphocytes in Multiple Sclerosis Patients during Interferon-β Therapy. NeuroImmunoModulation. 19(5). 283–292. 39 indexed citations
13.
Goretti, Benedetta, Angelo Ghezzi, Emilio Portaccio, et al.. (2010). Psychosocial issue in children and adolescents with multiple sclerosis. Neurological Sciences. 31(4). 467–470. 37 indexed citations
14.
Ghezzi, Angelo, Maria Pia Amato, Pietro Annovazzi, et al.. (2009). Long-term results of immunomodulatory treatment in children and adolescents with multiple sclerosis: the Italian experience. Neurological Sciences. 30(3). 193–199. 54 indexed citations
15.
Ghezzi, Angelo, Maria Pia Amato, Marco Capobianco, et al.. (2007). Treatment of early-onset multiple sclerosis with intramuscular interferonβ-1a: long-term results. Neurological Sciences. 28(3). 127–132. 44 indexed citations
16.
Filippi, Massimo, Marco Bozzali, & Giancarlo Comi. (2001). Magnetization transfer and diffusion tensor MR imaging of basal ganglia from patients with multiple sclerosis. Journal of the Neurological Sciences. 183(1). 69–72. 39 indexed citations
17.
Martino, Gianvito, Fabio Grohovaz, Elena Brambilla, et al.. (1998). Proinflammatory cytokines regulate antigen‐independent T‐cell Activation by two separate calcium‐signaling pathways in multiple sclerosis patients. Annals of Neurology. 43(3). 340–349. 43 indexed citations
18.
Comi, Giancarlo, Massimo Filippi, A. Campi, et al.. (1995). Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple sclerosis. Journal of the Neurological Sciences. 132(2). 222–227. 154 indexed citations
19.
Pozzilli, Carlo, C. Fieschi, Daniela Perani, et al.. (1992). Relationship between corpus callosum atrophy and cerebral metabolic asymmetries in multiple sclerosis. Journal of the Neurological Sciences. 112(1-2). 51–57. 29 indexed citations
20.
Martino, Gianvito, Luigi Maria Edoardo Grimaldi, Lucia Moiola, et al.. (1990). Discontinuos distribution of IgG oligoclonal bands in cerebrospinal fluid from multiple sclerosis patients. Journal of Neuroimmunology. 30(2-3). 129–134. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026